• Return to Headlines

Bluebird Bio Inc: 52-Week High Recently Eclipsed (BLUE)

By Nick Russo

Bluebird Bio Inc (NASDAQ:BLUE) traded at a new 52-week high today of $236.17. This new high was reached on below average trading volume as 89,000 shares traded hands, while the average 30-day volume is approximately 1.2 million shares.

Bluebird Bio, Inc. provides biotechnological products and services. The Company offers gene therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders, and beta-thalassemia. Bluebird Bio conducts its business in the United States.

In the past 52 weeks, Bluebird Bio Inc share prices have been bracketed by a low of $36.62 and a high of $236.17 and are now at $235.95, 544% above that low price. The 200-day and 50-day moving averages have moved 3.01% lower and 1.73% lower over the past week, respectively.

Bluebird Bio Inc (NASDAQ:BLUE) is currently priced 9.3% above its average consensus analyst price target of $214.00. The stock should find initial support at its 200-day moving average (MA) of $78.66 and further support at its 50-day MA of $46.60.

SmarTrend recommended that subscribers consider buying shares of Bluebird Bio Inc on February 16th, 2018 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $209.54. Since that recommendation, shares of Bluebird Bio Inc have risen 11.2%. We continue to monitor BLUE for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows bluebird bio inc

Ticker(s): BLUE